PI3K/AKT-mediated upregulation of WDR5 promotes colorectal cancer metastasis by directly targeting ZNF407. - Wikidata - wikimedia - TriplyDB

PI3K/AKT-mediated upregulation of WDR5 promotes colorectal cancer metastasis by directly targeting ZNF407.

PI3K/AKT-mediated upregulation of WDR5 promotes colorectal cancer metastasis by directly targeting ZNF407.

http://www.wikidata.org/entity/Q37745350

about

mRNA-miRNA bipartite network reconstruction to predict prognostic module biomarkers in colorectal cancer stage differentiation.Effect of long non-coding RNA Gas5 on proliferation, migration, invasion and apoptosis of colorectal cancer HT-29 cell line.ARHGEF19 interacts with BRAF to activate MAPK signaling during the tumorigenesis of non-small cell lung cancer.Up-regulated WDR5 promotes gastric cancer formation by induced cyclin D1 expression.Quercetin Inhibits the Migration and Invasion of HCCLM3 Cells by Suppressing the Expression of p-Akt1, Matrix Metalloproteinase (MMP) MMP-2, and MMP-9.A Network Pharmacology Approach to Uncover the Multiple Mechanisms of Hedyotis diffusa Willd. on Colorectal Cancer.WDR5 supports colon cancer cells by promoting methylation of H3K4 and suppressing DNA damage.

P2860

Q38598443-550BFB22-690C-4D60-A858-314CBBD30885 Q47225928-E358EDA4-11C1-444E-9C1D-E933E4B7A853 Q47375003-3854719B-80D0-4DD5-9C90-84EE072CEAEF Q47617965-1F94B161-36A5-4778-A7D3-C6857E7D878D Q54959300-3A68259B-AD51-4493-92B4-C12A7A67757C Q54990524-34E26AA9-111C-4726-B0DD-C5A71B25C874 Q55427338-80FF2226-64FB-4CFF-97A8-1673221BEC6A

P2860

PI3K/AKT-mediated upregulation of WDR5 promotes colorectal cancer metastasis by directly targeting ZNF407.

http://www.wikidata.org/entity/Q37745350

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 March 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

PI3K/AKT-mediated upregulation ...... by directly targeting ZNF407.

@en

PI3K/AKT-mediated upregulation ...... by directly targeting ZNF407.

@nl

type

label

PI3K/AKT-mediated upregulation ...... by directly targeting ZNF407.

@en

PI3K/AKT-mediated upregulation ...... by directly targeting ZNF407.

@nl

prefLabel

PI3K/AKT-mediated upregulation ...... by directly targeting ZNF407.

@en

PI3K/AKT-mediated upregulation ...... by directly targeting ZNF407.

@nl

P1433

Q37745350-C7156757-6146-4B77-BD02-1316307047D6

P1476

Q37745350-52703A65-2AD8-4BF0-A4C5-E820D9CF6E2E

P2093

Q37745350-257CA9F2-B316-4433-926D-F02208D0443C

Q37745350-2CB31D27-AF6D-4899-9E71-56BD7DCFA44A

Q37745350-398452AC-251A-4D75-8D8E-C57FE10A2D31

Q37745350-55C0D1A8-E033-49D5-B608-310C93F4C0FC

Q37745350-6A0F61C6-6BE4-4AE3-AC54-FF206F2A28F5

Q37745350-71596626-33A7-4960-869D-77F9E2D1103C

Q37745350-79E93AC0-568B-4E99-93A6-15F5503F79B2

Q37745350-8BEFE95C-9041-4697-A746-69DA53A8B9A1

Q37745350-961C6D5E-D54A-4499-9381-24F798E50B63

Q37745350-BE1B41DD-7871-44DB-8D6B-37E781968E56

P2860

Q37745350-00949FBC-5682-409C-99DA-1F7DFFADCE19

Q37745350-01211F40-DBD8-487D-A2D3-46F8493FE880

Q37745350-049AA049-ADEE-4F78-9E1B-19732D75434B

Q37745350-070C938F-31AB-4449-9E72-154A4BCEB5FC

Q37745350-0A9F8F8A-3A1A-42DE-BAE2-A39D32D3FB7E

Q37745350-0CF06F52-FBF1-49AF-BC5E-1A952DA84888

Q37745350-0E5A08A7-6D47-41FF-BE8C-199A86535AB8

Q37745350-13625A8A-2BDD-45BD-B81A-C54413DBF1C4

Q37745350-1FD909D6-3862-40A8-9E4A-48AE8CDC8989

Q37745350-1FE6779D-DD91-42E0-B695-235F1277B335

P304

Q37745350-2FA8B2F0-7217-4275-96F9-BCC8663E12DA

P31

Q37745350-651B126E-5831-440A-AC70-1F79F23783CD

P356

Q37745350-67424381-8846-4D78-AB8B-0C08118C5457

P433

Q37745350-4DB3BCBF-27E1-444E-B14E-DAB4AE904CE5

P478

Q37745350-4E07FF06-D501-49DE-BC64-1EF27787ABD1

P577

Q37745350-44C449CD-49AF-47A2-98E4-7D347725A174

P698

Q37745350-A0578E9C-3737-4082-92B1-72E1E6F9FD86

P921

Q37745350-AD8658FB-DD8D-444C-8460-D0D2FABD40A8

P932

Q37745350-D0F4CCFF-8F3B-43DE-9D58-91C803D249F3

P356

P1433

Cell Death and Disease

P1476

PI3K/AKT-mediated upregulation ...... by directly targeting ZNF407.

@en

P2093

Changchuan Pan

http://www.w3.org/2001/XMLSchema#string

Jiangxue Wu

http://www.w3.org/2001/XMLSchema#string

Jiaxin Lin

http://www.w3.org/2001/XMLSchema#string

Lin Qiu

http://www.w3.org/2001/XMLSchema#string

Ranyi Liu

http://www.w3.org/2001/XMLSchema#string

Rong Geng

http://www.w3.org/2001/XMLSchema#string

Shuai Chen

http://www.w3.org/2001/XMLSchema#string

Wenlin Huang

http://www.w3.org/2001/XMLSchema#string

Xiaofang Ying

http://www.w3.org/2001/XMLSchema#string

Xin Tan

http://www.w3.org/2001/XMLSchema#string

P2860

WDR5 interacts with mixed lineage leukemia (MLL) protein via the histone H3-binding pocket

The epithelial-mesenchymal transition generates cells with properties of stem cells

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Population-based programs for increasing colorectal cancer screening in the United States

Hijacked in cancer: the KMT2 (MLL) family of methyltransferases

Structure of WDR5 bound to mixed lineage leukemia protein-1 peptide

Characterization of a Novel WDR5-binding Site That Recruits RbBP5 through a Conserved Motif to Enhance Methylation of Histone H3 Lysine 4 by Mixed Lineage Leukemia Protein-1

How does multistep tumorigenesis really proceed?

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance

P304

e2686

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CDDIS.2017.111

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28300833

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

5386518

http://www.w3.org/2001/XMLSchema#string